Skip to Main Content

Paper Details

Temporary autonomic modulation with botulinum toxin type A to reduce atrial fibrillation after cardiac surgery.
Heart Rhythm
37
2019
BoNTA, POAF, Postoperative atrial fibrillation, atrial fibrillation, botulinum toxin type A, onabotulinumtoxinA, patients
Aged, Atrial Fibrillation, Autonomic Nervous System, Botulinum Toxins, Type A, Cardiac Surgical Procedures, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Neurotoxins, Postoperative Complications, Time Factors, Treatment Outcome
Author NameAffiliation
Nathan H WaldronDuke University Medical Center, North Carolina Duke Clinical Research Institute
Mary CooterDuke University Medical Center
John C HaneyDuke University Medical Center
Jacob N SchroderDuke University Medical Center
Jeffrey G GacaDuke University Medical Center
Shu S LinDuke University Medical Center
Martin I SigurdssonDuke University Medical Center
Martin I SigurdssonDuke University Medical Center
Marat FudimDuke Clinical Research Institute, Duke University Medical Center
Mihai V PodgoreanuDuke University Medical Center, North Carolina Duke Clinical Research Institute
Mark Stafford-SmithDuke University Medical Center
Carmelo A MilanoDuke University Medical Center
Jonathan P PicciniDuke Clinical Research Institute, Duke University Medical Center
Joseph P MathewDuke University Medical Center
  • 1 - 14

Datasets

Release 1.2